Bio-Techne Corporation (TECH)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Bio-Techne Corporation (TECH) is down 5.1% since the beginning of the year. At $56 per share, TECH is trading 22.9% below its 52-week high of $72. Investors who bought $1,000 worth of TECH shares 5 years ago would now be looking at an investment worth $512.

Bio-Techne Corporation (TECH) has returned -5.14% so far this year and 12.14% over the past 12 months. Over the last ten years, TECH has returned 7.82% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Dec 9, 1992, TECH's average daily return is +0.08%, while the average monthly return is +1.49%. At this rate, an investment would double in approximately 3.9 years.

Historically, 55% of months were positive and 45% were negative. The best month was Jun 2000 with a return of +66.4%, while the worst month was Jan 2022 at -27.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 5 months.

On a daily basis, TECH closed higher 49% of trading days. The best single day was May 1, 2003 with a return of +21.0%, while the worst single day was Oct 24, 2000 at -19.7%.

Bio-Techne Corporation has an annualized alpha of 12.94%, beta of 0.82, and R2 of 0.14 versus S&P 500 Index. Calculated based on daily prices since December 09, 1992.

• This stock captured 108.16% of S&P 500 Index gains but only 87.42% of its losses - a favorable profile for investors.
• R2 of 0.14 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

TECH ranks 49 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

Bio-Techne Corporation provided a 0.58% dividend yield over the last twelve months, with an annual payout of $0.32 per share.

The table displays the monthly dividend distributions for Bio-Techne Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Bio-Techne Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bio-Techne Corporation was 74.39%, occurring on Apr 7, 2003. Recovery took 1283 trading sessions.

The current Bio-Techne Corporation drawdown is 57.77%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Bio-Techne Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Bio-Techne Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.